For US healthcare professionals only.

Bleed protection* for whatever moves them

INDICATIONS: ELOCTATE® [Antihemophilic factor (recombinant), Fc fusion protein] is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Limitation of Use

ELOCTATE is not indicated for the treatment of von Willebrand disease.

*ELOCTATE® has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.1

icons_joint

See how ELOCTATE
protects Bleed and Joint Protection*

icons_molecule

Discover the
ELOCTATE MOA Powered by Fc Fusion

icons_calculator

Calculate your
patient’s dose help with dosing